C
oxsackieviruses are causative agents of myocarditis, meningitis, and pancreatitis and have also been implicated in the development of type 1 diabetes (1-4). There are six group B coxsackievirus serotypes (CVB1 to -6) within the Picornaviridae family. These viruses are icosahedral, nonenveloped, and approximately 300 Å in diameter, with a positive-sense single-stranded RNA genome (5) . The crystal structures of CVB3-M and CVB3-RD strains are available in the Protein Data Bank (PDB) (PDB identifiers [ID] 1COV and 4GB3) (6, 7) . The capsid has a Tϭ1 (pseudo Tϭ3) icosahedral architecture, is composed of four viral proteins (VP1 to -4), and has distinct topological features that are important to the function of the virus (Fig. 1A) . Each 5-fold icosahedral symmetry axis is surrounded by a depression called the canyon, where a known receptor binding site is located. A hydrophobic pocket that contains a "pocket factor," which is likely a lipid moiety, lies directly beneath the floor of the canyon. At the southern rim of the canyon, there is an elevated hypervariable region called the "puff" that is a known antigenic site (5, 8) .
Like other picornaviruses, CVB3 undergoes specific structural changes as it proceeds through the virus life cycle; these changes are critical for cellular entry and subsequent infection (9, 10) . Initially, the virus must bind to a specific host receptor to gain entry into the cell and begin the infection. Previous studies with poliovirus (PV) and human rhinovirus (HRV) showed that there are two distinct modes for virus binding to receptor: a loweraffinity binding event that can be trapped at low temperatures and a higher-affinity binding event that is fleeting and occurs near physiological temperatures (11) (12) (13) . In the picornavirus entry model, receptor binds into the virus canyon, pocket factor is lost, and the virus transitions to the altered particle, or A-particle (14, 15 ). The A-particle is expanded compared to mature infectious virus, has lost VP4, has exposed the N termini of VP1, and typically has lost the ability to bind the receptor (16) (17) (18) . Consequently, A-particle formed in solution has lost the ability to infect cells efficiently even though it has not yet lost the RNA genome. Previous studies have shown that mature infectious virus experiences transient structural rearrangements that are characterized by reversible partial exposure of VP4 and the N termini of VP1, a dynamic phenomenon referred to as "viral breathing" (19, 20) . The purpose of viral breathing is not yet known, but it may be relevant to the high-affinity binding of the receptor (12, 21) .
Most picornaviruses use molecules in the immunoglobulin superfamily (IgSF) as their cell entry receptors (22) (23) (24) (25) . All CVBs use the coxsackievirus and adenovirus receptor (CAR) (26, 27) , a cell adhesion molecule found in tight junctions (28) . CAR is comprised of an extracellular domain folded into subdomains, D1 and D2, a single membrane-spanning sequence, and a C-terminal intracellular domain. Crystal structures for both human CAR D1 (PDB ID 1F5W and 1KAC) and murine CAR D1D2 (PDB ID 3MJ7 and 3JZ7) have been reported (29) (30) (31) (32) .
A 22-Å resolution cryo-electron microscopy (cryo-EM) reconstruction of CVB3 complexed with CAR was previously interpreted with the CAR D1 structure (23) . Here we present a 9.0-Å resolution cryo-EM map of CVB3-CAR complex interpreted with each of the four available crystal structures of CAR. This analysis provides a consensus footprint of the receptor binding site onto the virus. The receptor footprint maps to the puff region and the northern rim of the canyon, largely overlapping with known picornavirus antigenic epitopes. This mode of binding is conserved across picornavirus species. When incubated at 37°C, soluble CAR (sCAR) catalyzed virus inactivation with saturating kinetics, generating the CVB3 A-particle. The 6.6-Å cryo-EM map of the A-particle shows global expansion, loss of CAR, and extensive RNA reorganization.
MATERIALS AND METHODS
Virus growth and purification. CVB3 strain 28 (CVB3/28), used for the decay experiments, was passaged twice through HeLa cells after the initial transfection with the infectious cDNA plasmid (33) and isolated as described previously (34) . The virus stock in 0.1 M NaCl was stored in aliquots at Ϫ80°C. Infectious CVB3/28 was quantitated as 50% tissue culture infectious doses (TCID 50 )/ml using RDt3 cells (a rhabdomyosarcoma cell line, RD CCL-136, that expresses coxsackievirus and adenovirus receptor [CAR] with a truncated cytoplasmic domain) (35) .
For cryo-EM studies, CVB3/28 DNA was transfected into confluent HeLa cells using Lipofectamine 2000 (Invitrogen). The lysate was collected 36 to 48 h posttransfection and centrifuged. The supernatant was used as first-passage stock to expand inoculum. Virus was propagated in HeLa cells and purified as previously described (36) . Briefly, infected cells were frozen and thawed three times, pelleted through a sucrose cushion, and purified by tartrate step gradient ultracentrifugation. Virus was collected and transferred to storage buffer using an Amicon centrifugal concentrator (Millipore) and four applications of 4 ml of 50 mM 2-(N-morpholino)ethanesulfonic acid (MES) buffer with 100 mM NaCl, pH 6.0. Virus concentration and quality were assessed by measuring absorbance at 260, 280, and 310 nm.
CAR production and purification. Soluble CAR (sCAR) was purified by immunoaffinity chromatography from medium conditioned by Raji cells transfected with pEF-ECAR (34) . sCAR protein concentration was determined by bicinchoninic acid (BCA) assay and purity established by Coomassie-stained SDS-PAGE. These sCAR preparations have previously been shown to inhibit CVB3 infection of cell lines (34) .
Cryo-EM reconstruction. CVB3/28 was incubated 1 h at 4°C with excess sCAR in a 1:180 ratio of virus capsid to receptor. An aliquot was applied to a Quantifoil grid and vitrified in a 50-50 mixture of propane and ethane. The remaining virus-receptor mixture was incubated for 30 min at 37°C prior to vitrification as described for the 4°C sample. Micrographs for the two independent data sets were recorded using a FEI Tecnai TF-20 FEG electron microscope operating at 200 kV on Kodak SO-163 film. Micrographs were digitized using a Super Coolscan 9000 with a scan step size of 6.35 m/pixel to generate a final pixel size of 1.25 Å/pixel. For each cryo-EM reconstruction, particles were selected using the program EMAN2 and defocus values for the micrographs were measured using the program ctffind3 (37) . A random model initiated the icosahedral reconstruction. An amplitude contrast factor of 7% was applied, and phases were flipped during data processing. The contrast transfer function (CTF) was fully corrected (38) during refinement. Final resolution was determined with maps with full CTF correction where the Fourier shell correlation was 0.5. Statistics for the cryo-EM reconstructions are presented in Table 1 .
The refined 9.0-Å CVB3-CAR complex reconstruction was mirrored across the x-y plane to "flip" the hand and generate a second map representing the stereoisomer. A calculated map was generated from the CVB3 crystal structure (PDB ID 1COV) (6) by mass weighting the atoms to simulate cryo-EM density and assigning a pixel size equal to 1 Å. Correct handedness was assessed by the quality of fit of the calculated map into the two cryo-EM density maps, by measuring correlation coefficients calculated about mean data value (cc) using the Chimera protocol Fit in Map (39) . With the correlation about mean option, the correlation can range from Ϫ1 to 1 as defined by Chimera. The absolute pixel size was determined by the fit that provided the highest correlation in the map of correct handedness.
Difference map and structure fitting of the complex map. A difference map was made by subtracting the density of the calculated map from that of the scaled cryo-EM map of CVB3/28 complexed with sCAR (38) . The CAR crystal structures (structural similarity quantified by root mean square deviation [RMSD] of 0.5 Å for the structure of D1) were fitted separately into the difference density and refined (40) (PDB ID 1F5W, 1KAC, 3MJ7, and 3JZ7) (29) (30) (31) (32) . The coordinates for each structure were superimposed to determine the similarity between structures after fitting, which raised the RMSD value between the structures to 1.2 Å (for D1). The crystal structure of CVB3 (PDB ID 1COV) was placed into density corresponding to virus, and the fit was refined (6, 40) . Atoms that were Յ4.0 Å apart and had the correct geometry between the fitted crystal structures of CVB3 and CAR were identified as potential contacts (41) . Buried surface was measured using the CCP4 program areaimol (41) .
Sequence alignment. All sequences were aligned using CLUSTAL W (42) . Sequence sources included the following (codes in parentheses are GenBank accession numbers unless otherwise specified): poliovirus (PDB ID 2PLV), CVA21 (PDB ID 1Z7Z), HRV14 (PDB ID 1RUF), HRV16 (PDB ID 1C8M), CVB1 (AFM77200, AFM77201, and AFM77204), CVB2 (AFM77213, AFM77210, and AFM77211), CVB3 (AFD33642, AAA42931, PDB ID 1COV and 4GB3, and AFM77189), CVB4 (AAB22446, ABF19105, and AAB33885), CVB5 (AFA28144, AEX07779, and AAW71476), and CVB6 (AAF12719 and Q9QL88). For the IgSF receptors, the accession numbers are as follows: PVR, AAF69803.1; CAR, P78310.1; and ICAM, 1403404A.
Virus decay analysis. Virus decay was assessed as previously reported (34) . Culture medium (high-glucose Dulbecco modified Eagle medium [DMEM], 10% fetal bovine serum, 0.9 mM glutamine, 90 U/ml of penicillin, 90 g/ml of streptomycin, and 67 g/ml gentamicin; all GIBCO brand, Life Technologies, Carlsbad, CA) was equilibrated overnight in a 37°C incubator with 6% CO 2 and refrigerated (4°C) prior to addition of CVB3 and sCAR. The cooled medium was dispensed into sterile 1.5-ml tubes, and sCAR was added to give the final experimental concentration after addition of CVB3/28. Prior to placing the sample into the 37°C 6% CO 2 incubator, an aliquot was removed and placed into a chilled 1.5-ml tube and frozen at Ϫ80°C pending TCID 50 assay. Subsequent samples were taken at timed intervals, placed into chilled 1.5-ml tubes, and stored at Ϫ80°C until assayed for infectious virus. Total incubation time was limited to no more than 84 h. TCID 50 analysis. For the TCID 50 assay, samples were thawed and kept chilled. The medium for sample dilution was cold (4°C), and 96-well plates were kept on chilled aluminum blocks while the samples were serially diluted and until 20 l from each dilution was placed into wells of a 96-well plate containing 100 l of medium and RDt3 cells plated the previous day at 3,000 to 4,000 per well. The inoculated plates were placed into the 37°C, 6% CO 2 incubator, and the microscopic cytopathic effect (CPE) was tallied every 24 h for 72 h. The final tally was used to calculate the TCID 50 /ml. Data points with ln(V t /V 0 ) (see below) values greater than Ϫ10 were used in the analyses. sCAR carryover into TCID 50 assays was apparent in the initial dilutions with high concentrations of sCAR but did not alter the TCID 50 values obtained with sCAR up to 1,000 nM and CVB3/28 at Ն1.5 ϫ 10 4 TCID 50 /ml. Each sample was evaluated twice, and the TCID 50 /ml results were averaged. Virus decay at each concentration of sCAR was analyzed on two separate occasions.
Kinetic analysis. First-order rate constants were determined by linear regression of the equation ln(V t /V 0 ) ϭ Ϫk · t ϩ b, where V 0 is the TCID 50 /ml at the time of first sampling, V t is the TCID 50 /ml at subsequent time points, t is hours elapsed since the initial sample was taken, and k is the first-order rate constant (h Ϫ1 ). Slopes at each concentration of sCAR were averaged (weighted by the number of points in the data set); propagation of standard errors of regression was calculated per the work of P. R. Bevington (43) . Nonzero values for the intercept, b, result from errors in determining V 0 . For graphical presentation, data sets were corrected to the equation ln(V t /V 0 ) ϭ Ϫk · t.
Six experiments were done with no sCAR, two of which were presented in the work of Carson et al. (34) . The additional four experiments from this study were used to calculate the average and variance in the previous report. In experiments with sCAR present with the virus, starting concentrations of CVB3 ranged from 1.58 ϫ 10 8 to 1.23 ϫ 10 9 TCID 50 /ml (except for one experiment at 2.76 ϫ 10 6 TCID 50 /ml). The lowest ratios of sCAR to number of binding sites (60 per The linear regression analyses of ln(V t /V 0 ) versus time were done with Pro-Stat v4.1 or PSI-Plot v8.1 for Windows (Poly Software International, Pearl River, NY). Nonlinear models were fit to the data using the Levenberg-Marquardt algorithm, or Powell's method, in PSI-Plot.
Structure fitting of the A-particle map. The structure of the A-particle of CVA16 (PDB ID 4JGY) (44) was fitted into the cryo-EM density map of the CVB3 A-particle using the program Situs (40) , treating the protomer as a rigid body and allowing each of the 60 symmetry-related protomers freedom during the fitting process. CVB3 (PDB ID 4GB3) (7) was also fitted using the same protocol. The coordinates for the fitted CVA16 and CVB3 structures were superimposed and an RMSD was determined with Chimera (39). Accession numbers. Cryo-EM maps for the CVB3-sCAR complex and the A-particle are deposited in the EM data bank (www.emdatabank .org/) under accession numbers EMD-5927 and EMD-5928. Fitted structures of CAR PDB ID 1F5W, 1KAC, 3MJ7, and 3JZ7 are deposited in the PDB under ID 3J6L, 3J6M, 3J6O, and 3J6N, respectively.
RESULTS

Virus-receptor complex cryo-EM map.
Cryo-electron microscopy (cryo-EM) and image analysis were used to reconstruct a 9.0-Å resolution density map of the CVB3-sCAR complex formed at 4°C (Fig. 1B) . The magnitude of the CAR density was nearly equal to that of the capsid, indicating full occupancy of the receptor binding sites. The virus capsid appeared unchanged, which was verified when the crystal structure of CVB (PDB ID 1COV) was fitted into the corresponding density of the cryo-EM complex map (6) . The two human CAR D1 structures (PDB ID 1F5W and 1KAC) (29, 30) and the two murine CAR D1D2 structures (PDB ID 3MJ7 and 3JZ7) (31, 32) were fitted into the receptor density in separate experiments (40) . Each fitted structure was used to interpret virus-receptor interactions, resulting in a consensus footprint of receptor on the virus ( Table 2 ). The predicted CAR interactions mapped to the puff region of the virus (loop EF, VP2 residues 129 to 180) and to the north rim of the canyon (Fig. 1) . However, there were no interactions with the canyon floor, as a separation between sCAR and the canyon could be distinguished in the 9.0-Å resolution map of the complex (Fig. 1E) . The distinct separation between receptor and CVB3 was not discernible at 22 Å (Fig. 2) , which was the resolution available in a previously reported map of the complex (23) .
Receptor footprint on the virus. The capsid protein sequence identity of group B coxsackieviruses is strongly conserved (88 to 100% sequence identity), and all CVBs use CAR as the receptor for cell entry (26, 27, 45) . The sequence of the VP2 protein, which comprises the puff region, is somewhat less conserved among CVBs, ranging from 63 to 100% identity. Members of the B group of coxsackievirus were aligned to examine conservation of resi- dues identified in the CAR binding site (Table 3) . Ten of the 20 contact residues are identical across the CVB group. Nine of those residues are in VP1 and map to the north rim of the canyon. This result suggests that residues at the north canyon rim, many of which have been previously identified in poliovirus (PV)-receptor binding studies (46) (47) (48) , make a major contribution to receptor binding ( Table 3 ). The CAR contact residues that map to the puff are variable across the B group of coxsackieviruses and thus might be considered less likely to affect CAR binding; however, an Asp at VP2 residue 139 is conserved within the footprint across all the CVBs. VP2 residue 165, which is a known determinant for cardiovirulence and thought to be involved in receptor recognition (49) , is also located within the puff portion of the CAR footprint.
The CAR footprint on CVB3 was compared to the IgSF receptor footprints for PV (50) , human rhinovirus (HRV) (24) , and coxsackievirus A21 (CVA21) (25) (Fig. 3) . Each of the four receptors interacts with its respective virus at the puff and north rim of the canyon; PV and HRV have additional receptor interactions at the south canyon rim. The common interactions with residues at the puff were unexpected because the puff is a region of high sequence variability, even among serotypes, and a known antigenic site. To investigate further, known antigenic sites for poliovirus (51, 52, 53, 54) and rhinovirus (55) were mapped on the aligned virus sequences (Fig. 4) , identifying distinct clusters of receptor binding residues, three in VP1 and two in VP2 (Fig. 4A) . Each of these clusters overlaps with a known antigenic epitope, except for cluster B, which consists of a group of conserved residues located at the north rim of the canyon (Fig. 4) . Across the four virus species, there is conservation among the north canyon rim residues within the receptor binding footprints. HRV16 and CVA21 share more sequence-equivalent amino acids with CVB3 within the receptor footprint region than are found overall within the VP1 proteins or the VP2 puff regions (Tables 3 and 4) . PV does not share this trait of increased amino acid conservation within the footprints; however, cluster C includes residues believed to be critical for PV to bind its receptor (Fig. 4) (46) .
The virus footprint on the receptor. A consensus footprint was also identified for the CVB3 interaction with the CAR protein.
The nine CAR amino acids predicted to interact with the virus capsid map to the N-terminal region of CAR (Table 5 ; Fig. 3A ). Receptor residues identified as critical for HRV binding map to the N-terminal region of ICAM-1 (57); however, these two canyon binding receptors appear to interact differently with their respective viruses (Fig. 3) . Although the IgSF members share structural similarities (Fig. 3) , they have low sequence identity (11 to 13%). Overall, there is more variation among the virus footprints on each respective receptor than is found in the receptor footprints on each virus (Fig. 3) .
Kinetic analysis. Picornavirus binding to IgSF receptors mediates conversion to A-particles (15) (16) (17) . The conversion of CVB3 to inactive particles (A-particles), with or without receptor, proceeded at 37°C with first-order kinetics (Fig. 5A to I ) as described by equation 1:
where V t is total concentration of infectious virus at time, t, [V R · sCAR] represents the proportion of receptor binding sites occupied, k 1 is the first-order rate constant without receptor, and k 2 is the maximum achievable rate catalyzed by soluble monomeric receptor. In this equation, spontaneous decay and receptormediated decay can be concurrent (i.e., parallel reactions for which binding receptor does not prevent decay via the mechanism associated with k 1 ). The observed rate constant is as follows: mechanisms are mutually exclusive, with a k 2 of 1.90 Ϯ 0.07 h Ϫ1 . Use of [sCAR] a in equation 2 results in a marginally improved fit (F test, P Ͻ 0.05; using Powell's method, k 2 ϭ 1.69 h Ϫ1 , K ϭ 0.06 ϫ 10 Ϫ9 , and a ϭ 1.39). Values of the empirical exponent, a, greater than 1 suggest positive cooperativity. Of these mathematical solutions, equation 2 is the simplest, and parallel reactions have been assumed in analyses of PV-receptor binding (12) . Considering the solutions for all three mathematical models, k 2 ranges from 1.69 to 1.90 h Ϫ1 , so the maximum sCAR-catalyzed rate is 17 to 19 times higher than the spontaneous rate of virus inactivation at 37°C. The comparable k 1 for poliovirus was reported as 0.5 h Ϫ1 , and with 245 nM soluble poliovirus receptor, the k app was 15.8 h Ϫ1 (58, 59) . The half-maximal effect of sCAR on k app was observed at PV  44  36  55  14  13  CVA21  39  73  56  18  25  HRV16  37  64  52  8  25 a Sequence from the three different poliovirus serotypes (PDB ID 2PLV, 3EPC, and 3EPF) were also aligned. There are no differences in amino acid identity within the receptor footprint. PDB ID for the viruses listed in the table are as follows: 2PLV, 1C8M, and 1Z7Z for PV, HRV16, and CVA21, respectively. b The VP1 canyon north rim consists of VP1 residues equivalent to CVB3 VP1 residues 89 to 91, 140 to 155, and 211 to 217. c The puff consists of VP2 residues equivalent to CVB3 VP2 residues 129 to 180. Equivalent residues corresponding to antigenic epitopes were plotted as follows: poliovirus epitope II (yellow boxes) and NIm-II (pink line) (52) ; N-AgIA, N-AgIB, and N-AgII (blue boxes) (51, 53, 54) ; and NImIA, NImIB, and NImII (red boxes) (55) . Residues interacting with the respective IgSF receptor are highlighted in yellow (24, 25, 50) . Neutralization escape mutations critical to PVR binding are highlighted in cyan (46) . The two overscores identify the sites of suppressing mutations that restore PVR binding to mutant PV (47) . Clusters A to C map to the north canyon rim, an important PVR binding region (48) . The aligned HRV14 sequence used to map the antigenic sites was removed for ease of viewing. (B to D) Road maps are shown as a surface projection with the canyon outlined (black) (71) . (B) The CVB3 surface is displayed by radial height; color key indicates the lowest (red) to highest (blue) surface features. (C) Sequence-equivalent residues that comprise the antigenic epitopes are mapped onto an asymmetric unit of CVB3 with those originating from the PV and HRV antigenic sites shown in green and blue, respectively. Residues described in both N-Ag and NIm epitopes are colored cyan, with epitope II as yellow. (D) The CVB3 CAR footprint with the antigenic epitopes outlined in red defines the overlap between receptor binding and antigenicity. The CAR footprint is displayed in shades of blue representing the consensus of fitting the four different structures of CAR, from dark blue for all four in agreement to light blue for one contact (see Table 2 ).
50.4 nM, which is lower than either of the K d (dissociation constant) values measured for poliovirus binding its receptor or the K d reported for monomeric CAR binding to CVB3 (12, 14) . The A-particle. Although heating native picornavirus has been an acceptable surrogate for receptor binding to produce the Aparticle (9, 60, 61) , for this structural study, mature CVB3 was incubated with excess sCAR at 37°C to produce the receptor-catalyzed A-particle. Global structural changes occurred during the Red font indicates residues that are disordered in the atomic structure. The structure of 1F5W was truncated (blue font) so that the N terminus was equivalent in length to that of sCAR. The yellow highlighted residues were identified from fitted CAR atoms no more than 4 Å from the fitted virus structure that had the proper geometry to be considered potential contacts. Red boxes outline the region of CAR that interacts with the virus puff and north canyon rim. The lower correlation coefficients (cc) for the D1-only structures were likely due to the lack of filled D2 density in the CAR difference density map. The four independently fitted CAR structures superimposed with an RMSD of 1.2. The X-ray structures used are from the two human D1 structures, PDB ID 1F5W (29) and 1KAC (30) , and two murine D1D2 structures, PDB ID 3MJ7 (31) and 3JZ7 (32) . Murine and human CARs share 90% sequence identity. transition to A-particle that resulted in the loss of CAR binding. The radial capsid expansion of ϳ5 Å was comparable to what has been reported for enterovirus 71 (EV71) (61), PV (62, 63) , and HRV (21, 56) . Notable structural changes include the formation of large open pores at each 2-fold axis of symmetry, a restructuring of the packaged RNA, and columns of density connecting the genomic RNA to the expanded capsid shell (Fig. 6) . Similar density columns were reported for the EV71 A-particle structure that was formed by heat treatment (61) . In the EV71 A-particle, the density columns were shown to contain the N terminus of VP1 ( Fig. 6B and C) . This location for VP1 was also found in a recent crystal structure of the A-particle of CVA16 (44) . Thus, the A-particle formed by incubation of CVB3 with sCAR shares the important features known from studies of A-particles generated by heating other picornaviruses.
The crystal structure of the CVA16 A-particle (PDB ID 4JGY) (44) (which shares 42% sequence identity with CVB3) fitted into our CVB3 A-particle cryo-EM density map with a correlation coefficient (cc) of 0.86. Since the protomer has been shown to move as a rigid body between expanded and nonexpanded forms of EV71 (64), the structure of CVB3 (PDB ID 4GB3) (7) was also fitted into the A-particle, resulting in a cc of 0.82. The experiment revealed that the 2-fold pore of the CVB3 A-particle is 20 by 31 Å in dimension, making it the largest in comparison to CVA16 and EV71 (44, 61) . Current models propose that one of the open pores at the 2-fold axes may be selected for formation of a unique portal for release of RNA (60, 61, 64, 66) . CVB3 residues in the CAR binding footprint (VP2 residues 136 to 140) align with CVA16 residues within a disordered loop (VP2 residues 137 to 141) (44) . This suggests that the conformational changes that occur to form the A-particle may induce flexibility that precludes receptor binding. Furthermore, the location of the emerging VP1 N terminus of the fitted CVA16 A-particle crystal structure maps beneath the CAR binding site, suggesting that loss of CAR binding is coincident with egress of VP1.
DISCUSSION
The three-dimensional structures and kinetics of the receptorcatalyzed conversion are consistent with a model that involves capsid breathing, a receptor-stabilized transition state, and conformational changes that occur on the path to genome delivery to the host. Icosahedral viruses are dynamic, with various vibrational modes; transition between antigenically distinct closed and open states of the capsid during a picornavirus breathing cycle has been documented both directly and indirectly (19, 20, 67, 68) . The open capsid conformation that occurs during the virus breathing cycle is reversible and exposes segments of VP1 and VP4 that are internalized in the closed state of the capsid. Only the open-state capsid is capable of binding the receptor with high affinity; therefore, the CVB3 open capsid is structurally distinct from the A-particle, which is incapable of high-affinity (or low-affinity) receptor binding.
According to the working model, when CVB3 encounters an appropriate CAR-expressing host cell, virus in the closed conformational state can bind to CAR via the low-affinity binding site, and it is this closed-conformation capsid bound to sCAR that has been visualized (Fig. 1) . The open conformation can occur in the absence of the receptor (20) , and the open and closed states exist in a temperature-dependent equilibrium. It is unlikely that the lowaffinity interaction of sCAR with the virus in closed conformation induces the open conformation. However, this low-affinity interaction may allow the virus to acquire the receptor in proximity to the transient high-affinity site (presumably within the canyon) that becomes available in the open conformation. CAR occupation of the high-affinity binding site likely increases the energy required to return to the closed conformation relative to that required for conversion to the A-particle. Poliovirus receptor lowered the activation energy for virion conversion, whereas ICAM-1 was found to accelerate the decay of HRV without altering the activation energy (56, 58) .
For polymers with multiple ligand binding sites that have conformation-dependent affinities, the presence of ligand can shift the equilibrium toward the high-affinity conformation, often with cooperativity (65) The receptor binding site available at low temperature is conserved within variable regions that are exposed on the virus surface, as has been described for foot-and-mouth disease virus (69) . Use of the highly conserved north canyon rim residues is consistent with the canyon hypothesis that states viruses may preserve receptor binding in areas hidden from immune surveillance (70) . The inaccessibility of the high-affinity binding site on the closed form of the virus indicates that this site is well hidden, perhaps deep in the canyon. The formation of the high-affinity binding site appears to be contingent on the conformational changes that take place when the capsid assumes the open conformation. The mechanisms to preserve receptor binding are conserved across species and suggest that a picornavirus takes advantage of multiple mechanisms for conserving two binding sites for the same receptor.
